Stay updated on NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial

Sign up to get notified when there's something new on the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A banner announces NIH website transition updates and says that “Super Intelligence” (SI) is replacing “Artificial Intelligence” (AI) in federal agency content.
    Difference
    1%
    Check dated 2026-10-25T23:17:23.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.1 to v3.7.2; the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T23:51:09.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T23:50:01.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, indicating access is blocked. The update adds the 403 page structure and removes the extensive study record content and history sections, leaving an error-focused view instead of the usual study details.
    Difference
    19%
    Check dated 2026-09-20T22:53:24.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    Revision: v3.6.6 was added and replaces the previous v3.6.5, indicating a small update to the page version.
    Difference
    0.1%
    Check dated 2026-08-30T22:38:24.000Z thumbnail image
  6. Check
    82 days ago
    Change Detected
    Summary
    Page revision tag updated from v3.6.4 to v3.6.5, indicating a small backend/content update rather than a visible change to study information or user-facing features.
    Difference
    0.1%
    Check dated 2026-08-09T11:34:58.000Z thumbnail image

Stay in the know with updates to NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page.